KYMR - Kymera Therapeutics Inc
IEX Last Trade
48.42
0.170 0.351%
Share volume: 622,969
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$48.25
0.17
0.35%
Summary score
9%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
2%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.95%
Return on assets
-6.24%
Return on sales
-348.26%
Return on invested capital
-93.75%
Total debt ratio
26.49%
Debt ratio change over timeo
-1.5%
Current Ratio
5.52%
Quick Ratio
5.52%
Cash Position Ratio
5.35%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.19%
Return on assets
-6.83%
Return on sales
-508.42%
Return on invested capital
-27.13%
Total debt ratio
25.76%
Debt ratio change over timeo
-2.09%
Current Ratio
6.83%
Quick Ratio
6.83%
Cash Position Ratio
6.51%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-6.83%
Return on assets
-6.09%
Return on sales
-514.3%
Return on invested capital
-17.67%
Total debt ratio
18.09%
Debt ratio change over time
-2.07%
Current Ratio
9.57%
Quick Ratio
9.57%
Cash Position Ratio
9.27%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.4%
Return on assets
-85.92%
Return on sales
734.94%
Return on invested capital
66%
Total debt ratio
-150.44%
Debt ratio change over time
-1.5%
Current Ratio
-15.46%
Quick Ratio
-15.46%
Cash Position Ratio
-14.91%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KYMR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.95% | 13.79% | 34.47% | 7.43% |
| Return on assets | -6.24% | 2.76% | 3.15% | 5.62% |
| Return on sales | -348.26% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -93.75% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 26.49% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.5% | 308.97% | -6.99% | 1.18% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 6.83% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.83% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.51% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 20% | 47% |
| Short-term ratios | KYMR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.19% | 13.77% | 13.25% | 3.8% |
| Return on assets | -6.83% | 2.43% | 1.89% | 3.09% |
| Return on sales | -508.42% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -27.13% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 25.76% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -2.09% | 46.38% | -72.08% | 1.51% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 6.83% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.83% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.51% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 19% | 48% |